Search Result "PCSK inhibitors"
PCSK 9: A Link Between Inflammation and Atherosclerosis
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 251-267
Author(s): Dimitri Patriki,Seyed Soheil Saeedi Saravi,Giovanni G. Camici,Luca Liberale,Jürg H. Beer
Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9(PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease
Journal: Current Vascular Pharmacology
Volume: 22 Issue: 1 Year: 2024 Page: 8-10
Author(s): Kosmas I. Paraskevas,Theofanis T. Papas
The LDL-Receptor and its Molecular Properties: From Theory to Novel Biochemical and Pharmacological Approaches in Reducing LDL-cholesterol
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 2 Year: 2020 Page: 317-333
Author(s): Dimitrios Petroglou,Ilias Kanellos,Christos Savopoulos,Georgia Kaiafa,Anastasios Chrysochoou,Panagiotis Skantzis,Stylianos Daios,Apostolos I. Hatzitolios,Georgios Giannoglou
Inhibition of Tumor Cells Proliferation and Migration by the Flavonoid Furin Inhibitor Isolated From Oroxylum indicum
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 4 Year: 2013 Page: 583-591
Author(s): C. Lalou,A. Basak,P. Mishra,B.C. Mohanta,R. Banik,B. Dinda,A.M. Khatib
PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1008-1014
Author(s): Ioannis Felekos,Grigoris V. Karamasis,Antonis N. Pavlidis
Discovery Approaches for Novel Dyslipidemia Drugs
Journal: Current Drug Discovery Technologies
Volume: 12 Issue: 2 Year: 2015 Page: 90-116
Author(s): Faheem Maqbool,Malihe Safavi,Haji Bahadar,Mahban Rahimifard,Kamal Niaz,Mohammad Abdollahi
Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 871-876
Author(s): Klaus G. Parhofer
Novel Circular, Cyclic and Acyclic ψ(CH2O) Containing Peptide Inhibitors of SKI- 1/S1P: Synthesis, Kinetic and Biochemical Evaluations
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2770-2782
Author(s): S. Majumdar, A. Chen, H. Palmer-Smith, A. Basak
The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3654-3657
Author(s): Eleni Theocharidou,Marianna Papademetriou,Andromachi Reklou,Alexandros Sachinidis,Chrisoula Boutari,Olga Giouleme
Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R)
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2168-2182
Author(s): H. Palmer-Smith, A. Basak